SEC Form 4 · accession 0001237899-15-000019
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George L Sing
Director
Period of report
Feb 20, 2015
Accepted (ET)
Feb 24, 2015 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2015 | M | 15,000 | $18.61 | A | 127,772 | D | |
| Common StockF1 | Feb 20, 2015 | S | 15,000 | $423.12 | D | 112,772 | D | |
| Common Stock | holding | — | — | — | 3,000 | I | by Spouse | |
| Common Stock | holding | — | — | — | 5,000 | I | by Spouse/Cust Son | |
| Common Stock | holding | — | — | — | 10,000 | I | by Trust for Son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $18.61 | Feb 20, 2015 | M | 15,000 | D | — | Jan 2, 2019 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 15,000 shares of Company stock on February 20, 2015 at prices ranging from $423.00 to $423.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 20, 2015 at each separate price.
- F2The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.